This compound reduces NRF2-dependent antioxidant defenses and affects metastatic potential in non-small-cell lung carcinoma (NSCLC) and head and neck squamous carcinoma models [87]. This evidence concerns the gene NFE2L2 and non-small cell lung carcinoma.